Showing 85 to 96 of 217 results
Class-Action Lawsuit Alleges Popular Food Packaging Releases Harmful Microplastics
A class-action lawsuit in California accuses a popular food packaging brand used by over 200 million Americans of misleading consumers about the safety of its microwaveable containers and bags, claiming they release harmful microplastics when heated or frozen; the lawsuit cites studies showing a 50%...
Class-Action Lawsuit Alleges Popular Food Packaging Releases Harmful Microplastics
A class-action lawsuit in California accuses a popular food packaging brand used by over 200 million Americans of misleading consumers about the safety of its microwaveable containers and bags, claiming they release harmful microplastics when heated or frozen; the lawsuit cites studies showing a 50%...
Progress
48% Bias Score
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
FDA Clears First Blood Test for Alzheimer's Diagnosis
The FDA approved Fujirebio Diagnostics' blood test for Alzheimer's diagnosis in those over 55 with symptoms; the test measures plasma proteins pTau217 and β-amyloid 1-42, showing 91% accuracy for positive and 97% for negative results in a study of almost 500 patients, offering a less invasive diagno...
Progress
36% Bias Score
FDA to Ban Prescription Children's Fluoride Supplements
The FDA, under Health Secretary Robert F. Kennedy Jr., will ban prescription fluoride supplements for children by October 31, citing microbiome concerns despite inconclusive research and opposition from major medical groups, potentially increasing childhood tooth decay.
FDA to Ban Prescription Children's Fluoride Supplements
The FDA, under Health Secretary Robert F. Kennedy Jr., will ban prescription fluoride supplements for children by October 31, citing microbiome concerns despite inconclusive research and opposition from major medical groups, potentially increasing childhood tooth decay.
Progress
52% Bias Score
FDA to Review, Potentially Remove, Children's Ingestible Fluoride Products
The FDA announced it will review ingestible fluoride prescription drugs for kids, aiming for removal by October 31, citing concerns regarding gut microbiome alteration and potential links to other health issues; this follows HHS Secretary Kennedy's call to end community water fluoridation, despite d...
FDA to Review, Potentially Remove, Children's Ingestible Fluoride Products
The FDA announced it will review ingestible fluoride prescription drugs for kids, aiming for removal by October 31, citing concerns regarding gut microbiome alteration and potential links to other health issues; this follows HHS Secretary Kennedy's call to end community water fluoridation, despite d...
Progress
60% Bias Score
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
FDA Approves At-Home Cervical Cancer Test
The FDA approved Teal Health's at-home cervical cancer test, the Teal Wand, a 96% accurate self-collection device designed to increase screening rates and potentially reduce the 4,000 annual U.S. deaths from cervical cancer by detecting HPV, the virus responsible for almost all cases.
Progress
36% Bias Score
FDA Appoints Covid-19 Vaccine Critic to Lead Biologics Division
The FDA appointed Dr. Vinay Prasad, a vocal critic of its Covid-19 policies, to head its Center for Biologics Evaluation and Research, replacing Dr. Peter Marks who resigned after criticizing HHS Secretary Robert F. Kennedy Jr. This appointment caused a 5% drop in biotech stocks and prompted concern...
FDA Appoints Covid-19 Vaccine Critic to Lead Biologics Division
The FDA appointed Dr. Vinay Prasad, a vocal critic of its Covid-19 policies, to head its Center for Biologics Evaluation and Research, replacing Dr. Peter Marks who resigned after criticizing HHS Secretary Robert F. Kennedy Jr. This appointment caused a 5% drop in biotech stocks and prompted concern...
Progress
48% Bias Score
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
FDA Clears First Blood Test for Early Alzheimer's Detection
The FDA approved the Lumipulse G blood test for early Alzheimer's detection in adults over 55 with symptoms; it measures blood plasma proteins, correlating with brain amyloid plaques, but requires combined clinical data for diagnosis; the test shows 91.7% accuracy in clinical trials.
Progress
24% Bias Score
Widespread Arsenic Contamination Found in U.S. Rice
A report reveals arsenic contamination in 100% of 145 U.S. rice samples tested, with 25% exceeding federal limits for infant rice cereal; experts advise dietary diversification, label checking (for growing region), and specific cooking methods to reduce exposure.
Widespread Arsenic Contamination Found in U.S. Rice
A report reveals arsenic contamination in 100% of 145 U.S. rice samples tested, with 25% exceeding federal limits for infant rice cereal; experts advise dietary diversification, label checking (for growing region), and specific cooking methods to reduce exposure.
Progress
40% Bias Score
FDA to Remove Prescription Fluoride Tablets and Drops
The FDA is initiating the removal of prescription fluoride tablets and drops from the market due to concerns over potential health risks, including microbiome alteration, following similar bans on water fluoridation in states like Utah and Florida; a safety review will be completed by October 31.
FDA to Remove Prescription Fluoride Tablets and Drops
The FDA is initiating the removal of prescription fluoride tablets and drops from the market due to concerns over potential health risks, including microbiome alteration, following similar bans on water fluoridation in states like Utah and Florida; a safety review will be completed by October 31.
Progress
56% Bias Score
FDA to Remove Prescription Fluoride Supplements for Children
The FDA announced it will remove prescription fluoride supplements for children from the market by October 31, citing potential health risks, despite dentists' opposing views; this follows actions by some states banning water fluoridation.
FDA to Remove Prescription Fluoride Supplements for Children
The FDA announced it will remove prescription fluoride supplements for children from the market by October 31, citing potential health risks, despite dentists' opposing views; this follows actions by some states banning water fluoridation.
Progress
44% Bias Score
FDA Delays Publishing Food Safety Warning Letters Due to Staff Layoffs
The FDA issued warning letters to several companies for serious food safety violations, including potential botulism contamination, but these haven't been published online due to staff layoffs under the Trump administration, delaying public awareness of potential risks.
FDA Delays Publishing Food Safety Warning Letters Due to Staff Layoffs
The FDA issued warning letters to several companies for serious food safety violations, including potential botulism contamination, but these haven't been published online due to staff layoffs under the Trump administration, delaying public awareness of potential risks.
Progress
24% Bias Score
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
FDA Appoints Vaccine Critic to Oversee Drug Program
Dr. Vinay Prasad, a critic of the FDA and COVID-19 measures, has been appointed to lead the agency's vaccine and biotech drug program, replacing Dr. Peter Marks who resigned after clashes with Robert F. Kennedy Jr. over vaccine safety. Prasad's appointment raises concerns about potential increased s...
Progress
52% Bias Score
Showing 85 to 96 of 217 results